Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

Division of Circulatory Physiology, Columbia University College of Physicians and Surgeons, New York, New York 10032.

OBJECTIVES. This study was conducted to determine the effect of long-term digoxin therapy on autonomic function in patients with mild to moderate chronic heart failure. BACKGROUND. Chronic heart failure is characterized by increased sympathetic activity and decreased parasympathetic activity. Intravenous digitalis has been found to reduce sympathetic activity immediately in these patients, but whether short-term neurohormonal effects are sustained during long-term oral therapy has not been assessed. METHODS. We determined sympathetic activity in 26 patients with heart failure by measuring plasma norepinephrine levels and parasympathetic activity from variables of heart period variability derived from 24-h ambulatory electrocardiographic Holter recordings obtained before and after 4 to 8 weeks of digoxin therapy. RESULTS. After digoxin therapy, plasma norepinephrine decreased significantly from a mean +/- SEM of 552 +/- 80 to 390 +/- 37 ng/ml. In addition, the RR interval increased significantly from 719 +/- 19 to 771 +/- 20 ms. High frequency power increased from 84 +/- 24 to 212 +/- 72 ms2, and the root mean square of successive differences in RR interval increased from 20.3 +/- 1.8 to 27.0 +/- 3.4 ms, indicating a substantial increase in parasympathetic activity. Low frequency power, an index of baroreflex activity, was also significantly increased (239 +/- 80 to 483 +/- 144 ms2) by digoxin therapy. CONCLUSIONS. These results indicate 1) that long-term therapy with digoxin acts to ameliorate the autonomic dysfunction of patients with heart failure, and 2) that the short-term neurohormonal effects of digoxin are sustained during prolonged treatment with the drug.

This article has been cited by other articles:

				F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The Sympathetic Nervous System in Heart Failure: Physiology, Pathophysiology, and Clinical Implications J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1747 - 1762. [Abstract] [Full Text] [PDF]

				R. Wensel, C. Jilek, M. Dorr, D. P. Francis, H. Stadler, T. Lange, F. Blumberg, C. Opitz, M. Pfeifer, and R. Ewert Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension Eur. Respir. J., October 1, 2009; 34(4): 895 - 901. [Abstract] [Full Text] [PDF]

				F. Nicolini and T. Gherli Alternatives to transplantation in the surgical therapy for heart failure Eur J Cardiothorac Surg, February 1, 2009; 35(2): 214 - 228. [Abstract] [Full Text] [PDF]

				P. R. Stanfield Homomers of Kir.3.4 in atrial myocytes: their relevance to atrial fibrillation J. Physiol., November 15, 2007; 585(1): 1 - 1. [Full Text] [PDF]

				M P Frenneaux Autonomic changes in patients with heart failure and in post-myocardial infarction patients Heart, November 1, 2004; 90(11): 1248 - 1255. [Abstract] [Full Text] [PDF]

				G.M. Felker, K. F. Adams Jr, W. A. Gattis, and C. M. O'Connor Anemia as a risk factor and therapeutic target in heart failure J. Am. Coll. Cardiol., September 1, 2004; 44(5): 959 - 966. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola Digitalis Therapy for Patients in Clinical Heart Failure Circulation, June 22, 2004; 109(24): 2942 - 2946. [Full Text] [PDF]

				M. Gheorghiade, K. F. Adams Jr, and W. S. Colucci Digoxin in the Management of Cardiovascular Disorders Circulation, June 22, 2004; 109(24): 2959 - 2964. [Full Text] [PDF]

				L. Fauchier, D. Babuty, A. Melin, P. Bonnet, P. Cosnay, and J. P. Fauchier Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances Eur J Heart Fail, March 1, 2004; 6(2): 181 - 185. [Abstract] [Full Text] [PDF]

				A. Berakis, T. J. Williams, M. T. Naughton, J. H. Martin, M. Muhlmann, and H. Krum Altered Sympathetic and Parasympathetic Activity in Lung Transplantation Patients at Rest and Following Autonomic Perturbation Chest, October 1, 2002; 122(4): 1192 - 1199. [Abstract] [Full Text] [PDF]

				J E Mietus, C-K Peng, I Henry, R L Goldsmith, and A L Goldberger The pNNx files: re-examining a widely used heart rate variability measure Heart, October 1, 2002; 88(4): 378 - 380. [Abstract] [Full Text] [PDF]

				K. F. Adams Jr, M. Gheorghiade, B. F. Uretsky, J. H. Patterson, T. A. Schwartz, and J. B. Young Clinical benefits of low serum digoxin concentrations in heart failure J. Am. Coll. Cardiol., March 20, 2002; 39(6): 946 - 953. [Abstract] [Full Text] [PDF]

				M. J. Hennessy, M. G. Tighe, C. D. Binnie, and L. Nashef Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep Neurology, November 13, 2001; 57(9): 1650 - 1654. [Abstract] [Full Text] [PDF]

				M. Petretta, L. Spinelli, F. Marciano, C. Apicella, M. L. E. Vicario, G. Testa, M. Volpe, and D. Bonaduce Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H86 - H92. [Abstract] [Full Text] [PDF]

				G. M. Verghese, L. B. Ware, B. A. Matthay, and M. A. Matthay Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema J Appl Physiol, October 1, 1999; 87(4): 1301 - 1312. [Abstract] [Full Text] [PDF]

				L. Fauchier, D. Babuty, P. Cosnay, and J. P. Fauchier Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1203 - 1207. [Abstract] [Full Text] [PDF]

				C. J. L. Little, P. O. O. Julu, S. Hansen, and S. W. J. Reid Real-time measurement of cardiac vagal tone in conscious dogs Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H758 - H765. [Abstract] [Full Text] [PDF]

				G. Grassi, D. Spaziani, G. Seravalle, G. Bertinieri, R. Dell'Oro, C. Cuspidi, and G. Mancia Effects of Amlodipine on Sympathetic Nerve Traffic and Baroreflex Control of Circulation in Heart Failure Hypertension, February 1, 1999; 33(2): 671 - 675. [Abstract] [Full Text] [PDF]

				J. B. Young, M. Gheorghiade, B. F. Uretsky, J. H. Patterson, and K. F. Adams Jr. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials J. Am. Coll. Cardiol., September 1, 1998; 32(3): 686 - 692. [Abstract] [Full Text] [PDF]

				F Bode, U Wiegand, W Raasch, G Richardt, and J Potratz Differential effects of defibrillation on systemic and cardiac sympathetic activity Heart, June 1, 1998; 79(6): 560 - 567. [Abstract] [Full Text]

				J. T. Sullebarger, P. M. D'Ambra, L. C. Clark, L. Thanikarry, and H. L. Fontanet Effect of Digoxin on Ventricular Remodeling and Responsiveness of {beta}-Adrenoceptors in Chronic Volume Overload Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 281 - 290. [Abstract] [PDF]

				D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota, and P. Merlet Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy : An In Vivo PET Study Circulation, November 18, 1997; 96(10): 3416 - 3422. [Abstract] [Full Text]

				M. Gheorghiade, V. B. Hall, G. Jacobsen, M. Alam, H. Rosman, and S. Goldstein Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors Circulation, October 1, 1995; 92(7): 1801 - 1807. [Abstract] [Full Text]